Live feed
Filing
SC 13D/A
SC 13D/A0000947871-20-000893·ORBIMED ADVISORS LLC
Schedule 13D ownership disclosure
ORIC Pharmaceuticals Inc
Security class unavailable · CUSIP: 68622P109
Event date: 2020-11-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-20-000893
- Form type
- SC 13D/A
- Filer
- ORBIMED ADVISORS LLC
- CIK
- CIK 1055951
- Filed
- Nov 18, 2020
- Reporting period
- Nov 17, 2020
- Description
- Schedule 13D beneficial ownership